Form 4: Alignment Healthcare Executive Sells Shares After Performance Share Units Vest

Christopher J. Joyce, Chief Legal and Administrative Officer of Alignment Healthcare, sold shares to cover tax obligations after performance share units vested due to the achievement of performance objectives.

Summary

• Christopher J. Joyce, Chief Legal and Administrative Officer of Alignment Healthcare, reported changes in beneficial ownership.
• On March 4, 2025, Joyce acquired 58,400 shares of common stock upon the vesting of performance share units (PSUs).
• The PSUs vested because Alignment Healthcare achieved certain performance objectives related to health plan revenue growth, at-risk returning member medical benefit ratio, and adjusted EBITDA, less capital expenditures.
• 50% of the granted PSUs vested on March 4, 2025, and the remaining 50% will vest on December 31, 2025, contingent upon continued service.
• Joyce sold 25,000 shares on March 4, 2025, at a weighted-average price of $15.5846 per share, pursuant to a Rule 10b5-1 plan adopted on November 27, 2024.
• On March 6, 2025, Joyce sold 10,871 shares at a weighted-average price of $15.53 per share to cover tax withholding obligations related to the PSU vesting.
• Following these transactions, Joyce beneficially owns 386,974 shares of Alignment Healthcare common stock.

Sentiment

Score: 6

Explanation: The document is neutral. It primarily reports transactions related to executive compensation. The achievement of performance objectives is a positive sign, but the stock sales are routine.

Positives

• The vesting of PSUs indicates that Alignment Healthcare achieved its performance objectives related to revenue growth, medical benefit ratio, and adjusted EBITDA.

Future Outlook

Fifty percent (50%) of the granted PSUs will become vested on December 31, 2025, subject to the reporting person's continued service to the Company on such vesting date.

Industry Context

Executive stock transactions are common and are often scrutinized by investors for insights into management's perspective on the company's future prospects. Sales to cover tax obligations are typical after vesting events.

Comparison to Industry Standards

• Executive compensation packages often include performance-based equity awards like PSUs to align management's interests with those of shareholders.
• Rule 10b5-1 plans are frequently used by executives to schedule stock sales in advance and avoid accusations of insider trading.
• The specific performance metrics used for PSU vesting (revenue growth, medical benefit ratio, EBITDA) are common in the healthcare industry.

Stakeholder Impact

• The vesting of PSUs and subsequent stock sales may have a minor impact on shareholders, but the transactions appear routine and related to compensation.

Key Dates